Literature DB >> 1679436

Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis.

S D Tyler1, W M Johnson, H Lior, G Wang, K R Rozee.   

Abstract

A set of synthetic oligonucleotide primers was designed for use in a polymerase chain reaction protocol to specifically detect the B subunit genes in vtx2ha and vtx2hb, which code for the production of the VT2 (Shiga-like toxin II) variant cytotoxins VT2v-a and VT2v-b, respectively. An additional set of primers amplified a fragment common to the B subunits of the VT2 and the VT2 variant genes. Subsequent restriction endonuclease digestion of this amplicon permitted prediction of specific VT2 and variant genotypes on the basis of predetermined restriction fragment length polymorphisms. Genotypes of 21 VT2-producing strains of Escherichia coli were determined using this polymerase chain reaction-restriction fragment length polymorphism procedure. Four strains contained B subunit target sequences only for VT2 genes, 9 strains contained sequences only for VT2v-a genes, and 3 strains contained sequences only for VT2v-b. For genes in combination, one strain contained B subunit genes for both VT2 and VT2v-a and two strains contained B subunit genes for VT2 and VT2v-b. Two strains of E. coli O91:H21 contained both VT2v-a and VT2v-b B subunit genes. The VT2 reference strain of E. coli, E32511, was found to contain the targeted sequences from both VT2 and VT2v-a genes, whereas the recombinant E. coli, pEB1, possessed only that of the VT2 gene. The specific activities of extracellular VT2 determined in HeLa cells ranged from 0.3 to 41.7 TCD50 per microgram of protein in strains carrying the VT2 gene target and from 0 to 50.0 TCD50 per microgram of protein in strains carrying only the VT2 variant target (TCD50 is the tissue culture dose by which 50% of the cells were affected), suggesting that phenotypic expression does not correlate with genotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679436      PMCID: PMC270112          DOI: 10.1128/jcm.29.7.1339-1343.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Differentiation of genes coding for Escherichia coli verotoxin 2 and the verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction.

Authors:  W M Johnson; D R Pollard; H Lior; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Serological differences between verocytotoxin 2 and shiga-like toxin II.

Authors:  S C Head; M A Karmali; M E Roscoe; M Petric; N A Strockbine; I K Wachsmuth
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

6.  Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family.

Authors:  V P Gannon; C Teerling; S A Masri; C L Gyles
Journal:  J Gen Microbiol       Date:  1990-06

7.  Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.

Authors:  D R Pollard; W M Johnson; H Lior; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511.

Authors:  C K Schmitt; M L McKee; A D O'Brien
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).

Authors:  Y Oku; T Yutsudo; T Hirayama; A D O'Brien; Y Takeda
Journal:  Microb Pathog       Date:  1989-02       Impact factor: 3.738

View more
  58 in total

1.  Characterization of a recurrent clonal type of Escherichia coli O157:H7 causing major outbreaks of infection in Scotland.

Authors:  L J Allison; P E Carter; F M Thomson-Carter
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan.

Authors:  Y Nishikawa; Z Zhou; A Hase; J Ogasawara; T Cheasty; K Haruki
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

5.  Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.

Authors:  Alejandra Krüger; Paula M A Lucchesi; Alberto E Parma
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

6.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR.

Authors:  K Ramotar; B Waldhart; D Church; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157.

Authors:  A Thomas; H R Smith; B Rowe
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

10.  Evaluation of a technique for identification of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction and digoxigenin-labeled probes.

Authors:  D Begum; N A Strockbine; E G Sowers; M P Jackson
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.